Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan;38(1):9-14.
doi: 10.1093/schbul/sbr133. Epub 2011 Sep 28.

Is the acute NMDA receptor hypofunction a valid model of schizophrenia?

Affiliations

Is the acute NMDA receptor hypofunction a valid model of schizophrenia?

Albert Adell et al. Schizophr Bull. 2012 Jan.

Abstract

Several genetic, neurodevelopmental, and pharmacological animal models of schizophrenia have been established. This short review examines the validity of one of the most used pharmacological model of the illness, ie, the acute administration of N-methyl-D-aspartate (NMDA) receptor antagonists in rodents. In some cases, data on chronic or prenatal NMDA receptor antagonist exposure have been introduced for comparison. The face validity of acute NMDA receptor blockade is granted inasmuch as hyperlocomotion and stereotypies induced by phencyclidine, ketamine, and MK-801 are regarded as a surrogate for the positive symptoms of schizophrenia. In addition, the loss of parvalbumin-containing cells (which is one of the most compelling finding in postmortem schizophrenia brain) following NMDA receptor blockade adds construct validity to this model. However, the lack of changes in glutamic acid decarboxylase (GAD(67)) is at variance with human studies. It is possible that changes in GAD(67) are more reflective of the neurodevelopmental condition of schizophrenia. Finally, the model also has predictive validity, in that its behavioral and transmitter activation in rodents are responsive to antipsychotic treatment. Overall, although not devoid of drawbacks, the acute administration of NMDA receptor antagonists can be considered as a good model of schizophrenia bearing a satisfactory degree of validity.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Expression of parvalbumin (PV) mRNA in the medial prefrontal cortex of the rat. (A) Low magnification pseudocolored picture showing the distribution pattern of PV in a saline-injected rat. (B) High magnification photomicrograph of the area delimited in (A) showing the predominant distribution of PV within layers 3 and 5 in the infralimbic region of the medial prefrontal cortex. (C) Reduced level of PV mRNA after 1 mg/kg of MK-801. (D) Bar graphs showing the mean ± standard error of the mean of PV mRNA of rats injected with saline or MK-801; *P < .05. Dashed line shows the localization of cerebral midline, and Arabic numbers indicate the different cortical layers (note the absence of layer 4 in the medial prefrontal cortex of the rat). Scale bars: 2 mm in (A) and 600 μm in (B) and (C).

References

    1. Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R. Study of a new schizophrenomimetic drug; sernyl. AMA Arch Neurol Psychiatry. 1959;81:363–369. - PubMed
    1. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 1991;148:1301–1308. - PubMed
    1. Akbarian S, Sucher NJ, Bradley D, et al. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci. 1996;16:19–30. - PMC - PubMed
    1. Pilowsky LS, Bressan RA, Stone JM, et al. First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients. Mol Psychiatry. 2006;11:118–119. - PubMed
    1. Stone JM, Erlandsson K, Arstad E, et al. Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy: a [123I]CNS-1261 SPET study. Psychopharmacology (Berl) 2008;197:401–408. - PubMed

Publication types

MeSH terms